131 related articles for article (PubMed ID: 38599298)
1. Synthesis and antiproliferative activity of a tetrahydrofuran analog of FR901464.
Pohorilets I; Beard JP; Driscoll JL; Schmitz JC; Koide K
Bioorg Med Chem Lett; 2024 May; 104():129739. PubMed ID: 38599298
[TBL] [Abstract][Full Text] [Related]
2. Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue.
Albert BJ; Sivaramakrishnan A; Naka T; Czaicki NL; Koide K
J Am Chem Soc; 2007 Mar; 129(9):2648-59. PubMed ID: 17279752
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.
Osman S; Albert BJ; Wang Y; Li M; Czaicki NL; Koide K
Chemistry; 2011 Jan; 17(3):895-904. PubMed ID: 21226105
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective total syntheses of FR901464 and spliceostatin A and evaluation of splicing activity of key derivatives.
Ghosh AK; Chen ZH; Effenberger KA; Jurica MS
J Org Chem; 2014 Jun; 79(12):5697-709. PubMed ID: 24873648
[TBL] [Abstract][Full Text] [Related]
5. Antitumor compounds based on a natural product consensus pharmacophore.
Lagisetti C; Pourpak A; Jiang Q; Cui X; Goronga T; Morris SW; Webb TR
J Med Chem; 2008 Oct; 51(19):6220-4. PubMed ID: 18788726
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective syntheses of FR901464 and spliceostatin A: potent inhibitors of spliceosome.
Ghosh AK; Chen ZH
Org Lett; 2013 Oct; 15(19):5088-91. PubMed ID: 24050251
[TBL] [Abstract][Full Text] [Related]
7. Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.
Albert BJ; McPherson PA; O'Brien K; Czaicki NL; Destefino V; Osman S; Li M; Day BW; Grabowski PJ; Moore MJ; Vogt A; Koide K
Mol Cancer Ther; 2009 Aug; 8(8):2308-18. PubMed ID: 19671752
[TBL] [Abstract][Full Text] [Related]
8. Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.
Lagisetti C; Yermolina MV; Sharma LK; Palacios G; Prigaro BJ; Webb TR
ACS Chem Biol; 2014 Mar; 9(3):643-8. PubMed ID: 24377313
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes.
Motoyoshi H; Horigome M; Ishigami K; Yoshida T; Horinouchi S; Yoshida M; Watanabe H; Kitahara T
Biosci Biotechnol Biochem; 2004 Oct; 68(10):2178-82. PubMed ID: 15502365
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic Spliceostatin Analogs from Pseudomonas sp.
Zhao H; Zhang B; Ma LF; Shi LM; Zhan ZJ
Chem Biodivers; 2019 Sep; 16(9):e1900266. PubMed ID: 31298476
[TBL] [Abstract][Full Text] [Related]
11. FR901464: total synthesis, proof of structure, and evaluation of synthetic analogues.
Thompson CF; Jamison TF; Jacobsen EN
J Am Chem Soc; 2001 Oct; 123(41):9974-83. PubMed ID: 11592876
[TBL] [Abstract][Full Text] [Related]
12. SPIKET and COBRA compounds as novel tubulin modulators with potent anticancer activity.
Uckun FM; Mao C; Jan ST; Huang H; Vassilev AO; Sudbeck EA; Navara CS; Narla RK
Curr Opin Investig Drugs; 2000 Oct; 1(2):252-6. PubMed ID: 11249582
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives.
Szücová L; Spíchal L; Dolezal K; Zatloukal M; Greplová J; Galuszka P; Krystof V; Voller J; Popa I; Massino FJ; Jørgensen JE; Strnad M
Bioorg Med Chem; 2009 Mar; 17(5):1938-47. PubMed ID: 19232496
[TBL] [Abstract][Full Text] [Related]
14. Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1.
Pham D; Koide K
Nat Prod Rep; 2016 May; 33(5):637-47. PubMed ID: 26812544
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective synthesis of spliceostatin E and evaluation of biological activity.
Ghosh AK; Veitschegger AM; Sheri VR; Effenberger KA; Prichard BE; Jurica MS
Org Lett; 2014 Dec; 16(23):6200-3. PubMed ID: 25423085
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective Synthesis of a Cyclopropane Derivative of Spliceostatin A and Evaluation of Bioactivity.
Ghosh AK; Reddy GC; Kovela S; Relitti N; Urabe VK; Prichard BE; Jurica MS
Org Lett; 2018 Nov; 20(22):7293-7297. PubMed ID: 30394756
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological investigations of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)benzimidazoles.
Novelli F; Tasso B; Sparatore F; Sparatore A
Farmaco; 1997; 52(8-9):499-507. PubMed ID: 9507658
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological investigations of 1-(tetrahydropyran-2'-yl)- and 1-(tetrahydrofuran-2'-yl)benzimidazoles and 1/2-(tetrahydropyran-2'-yl)- and 1/2-(tetrahydrofuran-2'-yl)benzotriazoles.
Sparatore A; Novelli F; Sparatore F
Farmaco; 1997; 52(8-9):509-21. PubMed ID: 9507659
[TBL] [Abstract][Full Text] [Related]
19. A versatile stereocontrolled approach to chiral tetrahydrofuran and tetrahydropyran derivatives by use of sequential asymmetric Horner-Wadsworth-Emmons and ring-closure reactions.
Vares L; Rein T
J Org Chem; 2002 Oct; 67(21):7226-37. PubMed ID: 12375948
[TBL] [Abstract][Full Text] [Related]
20. A dioxane template for highly selective epoxy alcohol cyclizations.
Mousseau JJ; Morten CJ; Jamison TF
Chemistry; 2013 Jul; 19(30):10004-16. PubMed ID: 23775936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
